Page 6 - Gastroenterology At Takeda Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gastroenterology at takeda pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gastroenterology At Takeda Pharmaceuticals Today - Breaking & Trending Today

Non-alcoholic fatty liver disease increases cardiovascular and mortality risk in patients with diabetes

1. The risk of cardiovascular disease (CVD) and all-cause death for individuals with type 2 diabetes mellitus (T2DM) is increased for those with non-alcoholic fatty liver disease (NAFLD) compared to those without NAFLD. Evidence Rating Level: 2 (Good) Non-alcoholic fatty liver disease (NAFLD) is increasing in prevalence globally. Patients with NAFLD are at an increased ....

South Korea , Minute Medicine Inc , National Health Screening Program In Korea , Rating Level , National Health Screening Program , Cardiovascular Disease , Chronic Disease ,

A Multidisciplinary Approach to Managing VOD

Sergio Giralt, MD, leads a discussion on the importance of a multidisciplinary team approach in caring for patients with VOD, from recognizing early signs to treating and monitoring the disease. ....

Al Qahirah , Sergio Giralt , York Medical College , Memorial Sloan Kettering Cancer Center , New York Medical College , Memorial Sloan Kettering Cancer , Veno Occlusive Disease , Multidisciplinary Care Team , Enlarged Liver , Fluid Retention , Renal Team ,

5 numbers to know on the gastroenterology workforce

Discover the latest numbers on the state of the gastroenterology workforce, including burnout rates, malpractice risks, and more from Medscape reports. ....

Turnout Rates , Alpractice Rates , Happy Marriage , Urnt Out Specialties , Side Gigs , Ued For Malpractice , Female Physicians ,

The rise of GI pay: 10-year timeline

Discover the evolution of average annual salaries for gastroenterologists over the past decade, with a 47% increase. ....

Physician Compensation , Highest Paid , Average Salary , Physician Compensation Survey ,

Long Time Coming: Pediatric Gastroenterologists React to New Dupilumab EoE Approval

Following the January 25, 2024 approval of dupilumab for eosinophilic esophagitis in patients 1-11 years of age, a trio of pediatric gastroenterologists shares their thoughts on the new indication, their anticipated priority of use, and potential hurdles to optimal treatment uptake. ....

Elizabeth Spencer , Riha Bhatt , Drug Administration , Vanderbilt University Medical Center , Icahn School Of Medicine At Mount Sinai , Regeneron Pharmaceutical , Biologics License Application , Priority Review , Icahn School , Mount Sinai , Mount Sinai Kravis Children , Priority Review Application , Pediatric Eosinophilic , Eosinophilic Esophagitis ,